MOSCHETTA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 14.271
AS - Asia 5.681
EU - Europa 5.123
SA - Sud America 1.651
AF - Africa 331
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.073
Nazione #
US - Stati Uniti d'America 14.019
SG - Singapore 2.313
IT - Italia 1.947
BR - Brasile 1.333
CN - Cina 1.275
HK - Hong Kong 704
SE - Svezia 632
RU - Federazione Russa 566
DE - Germania 470
VN - Vietnam 419
FI - Finlandia 319
FR - Francia 309
GB - Regno Unito 300
UA - Ucraina 220
BD - Bangladesh 192
IN - India 178
CI - Costa d'Avorio 142
CA - Canada 118
ID - Indonesia 111
AR - Argentina 102
IQ - Iraq 80
NL - Olanda 77
MX - Messico 71
TR - Turchia 69
ZA - Sudafrica 63
PK - Pakistan 50
EC - Ecuador 49
CO - Colombia 44
JP - Giappone 43
VE - Venezuela 43
SA - Arabia Saudita 42
PL - Polonia 41
IE - Irlanda 39
BE - Belgio 37
AT - Austria 36
ES - Italia 36
UZ - Uzbekistan 30
MA - Marocco 26
PH - Filippine 24
PY - Paraguay 24
CL - Cile 21
MY - Malesia 19
PE - Perù 19
KE - Kenya 18
TN - Tunisia 18
LT - Lituania 17
CZ - Repubblica Ceca 16
EG - Egitto 15
JO - Giordania 14
KR - Corea 14
IL - Israele 13
JM - Giamaica 12
AU - Australia 11
DZ - Algeria 11
NP - Nepal 10
ET - Etiopia 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
CH - Svizzera 8
PS - Palestinian Territory 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
PT - Portogallo 7
UY - Uruguay 7
HN - Honduras 6
PA - Panama 6
SV - El Salvador 6
AO - Angola 5
AZ - Azerbaigian 5
BH - Bahrain 5
CR - Costa Rica 5
GR - Grecia 5
GT - Guatemala 5
IR - Iran 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
KW - Kuwait 4
RO - Romania 4
RS - Serbia 4
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
PR - Porto Rico 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
BJ - Benin 2
BN - Brunei Darussalam 2
CV - Capo Verde 2
EU - Europa 2
HR - Croazia 2
IM - Isola di Man 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
Totale 27.030
Città #
Fairfield 1.654
Ashburn 1.435
Singapore 1.210
Woodbridge 1.136
Houston 823
Chandler 733
San Jose 720
Hong Kong 695
Seattle 612
Cambridge 603
Wilmington 535
Milan 529
Nyköping 493
Jacksonville 479
Ann Arbor 464
Beijing 379
Bari 275
New York 236
Lauterbourg 202
Los Angeles 191
Lawrence 190
Roxbury 188
Nanjing 183
Rome 183
Helsinki 146
Abidjan 142
Dallas 139
Dearborn 126
Ho Chi Minh City 122
Des Moines 113
Santa Clara 112
Council Bluffs 110
Munich 101
Boardman 99
Inglewood 97
Buffalo 96
Columbus 96
Hanoi 91
São Paulo 91
Princeton 89
Brooklyn 87
Chicago 81
Jakarta 78
San Diego 77
London 65
Falkenstein 58
Shenyang 49
Hebei 43
Montreal 42
Nuremberg 42
Figino 41
Frankfurt am Main 40
Rio de Janeiro 39
Atlanta 38
Dublin 38
Moscow 38
Brussels 34
Dong Ket 34
Naples 34
Turku 34
Jiaxing 33
Tokyo 33
Turin 33
Nanchang 32
Denver 31
Warsaw 31
Belo Horizonte 30
Guangzhou 30
Orem 30
San Francisco 30
San Giovanni Teatino 30
Chennai 29
Johannesburg 28
Phoenix 26
Salt Lake City 26
Toronto 26
Tashkent 25
Baghdad 24
Cressa 24
Curitiba 24
Paris 24
Tianjin 24
Dhaka 23
Istanbul 23
Porto Alegre 23
Brasília 22
Da Nang 22
Poplar 22
Changsha 20
Mexico City 20
Boston 19
Hefei 19
Indianapolis 19
Lahore 18
Manchester 18
The Dalles 18
Haiphong 17
Nairobi 17
Pescara 17
Redwood City 17
Totale 17.887
Nome #
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 464
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators 259
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice 252
Gut Microbiota Modulation and Its Implications on Neuropathic Pain: A Comprehensive Literature Review 226
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours 204
PGC-1α induced browning promotes involution and inhibits lactation in mammary glands 197
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 196
Adenomatous polyposis coli (APC)-induced apoptosis of HT29 colorectal cancer cells depends on mitochondrial oxidative metabolism 194
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil 191
Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse 191
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa 190
Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis 189
Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate 188
Role of oleic acid in the gut-liver axis: From diet to the regulation of its synthesis via Stearoyl-CoA desaturase 1 (SCD1) 188
Extra virgin olive oil: Lesson from nutrigenomics 185
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19 181
Extra-virgin olive oil from Apulian cultivars and intestinal inflammation 181
Sindrome metabolica e lavoro 180
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 177
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations 176
Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice 172
Atherosclerosis: lessons from LXR and the intestine. 171
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. 171
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes 165
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice 165
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice 161
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. 161
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari 158
Nuclear receptors in regenerating liver and hepatocellular carcinoma 157
A phylogenetic survey of biliary lipids in vertebrates 155
A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia 153
Bile acids lower triglyceride levels via a pathway involving FXR, SHP and SREBP1c 152
Hepatic-specific PPARa-FGF21 action in NAFLD 148
The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors 148
let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects 148
Pathophysiology of cholesterol gallstone disease 146
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. 146
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open-label pilot trial. 146
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 145
Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame? 143
Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2 143
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure 143
A translational view on the biliary lipid secretory network 142
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 142
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis 141
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis 141
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption 139
The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids 139
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 139
Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction 139
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR? 138
The emerging discipline of precision cooking: a suitable tool for the precision nutrition 137
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants 136
The FXR-FGF19 Gut-Liver Axis as a Novel "hepatostat" 136
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin 135
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. 135
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 135
Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer 134
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer 133
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 133
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes 132
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 132
Intestinal ecology in the metabolic syndrome 132
Primary sclerosing cholangitis: updates in diagnosis and therapy. 131
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome 129
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio 129
Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles 128
Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice 128
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis 128
Enterocyte superoxide dismutase 2 deletion drives obesity 128
Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients 127
Pathways of cholesterol crystallization in model bile and native bile 127
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD) 127
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis. 127
Water handling and aquaporins in bile formation: recent advances and research trends 127
LA SINDROME METABOLICA NEGLI ADDETTI ALLA PESCA MARITTIMA 127
Extra virgin olive oil extracts modulate the inflammatory ability of murine dendritic cells based on their polyphenols pattern: Correlation between chemical composition and biological function 127
Welcoming Foxa2 in the bile acid entourage 126
Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1) 126
Another one bites the gut: Nuclear receptor lrh-1 in intestinal regeneration and cancer 126
Adhesion of platelets to colon cancer cells is necessary to promote tumor development in xenograft, genetic and inflammation models 126
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 125
Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study 124
Nuclear receptors and cholesterol metabolism in the intestine 124
Tissue-specific actions of FXR in metabolism and cancer. 124
Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome 124
Preface: a special issue on nuclear receptors with a special view on the molecular basis of disease. 123
Asymmetric distribution of phosphatidylcholine and sphyngomyelin between micellar and vesicular phases: potential implication for canalicular bile formation 123
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1 123
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. 123
Bile acids and colon cancer: Solving the puzzle with nuclear receptors 122
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 122
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link 121
Linking transcription to physiology in lipidomics 121
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis 120
Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms 119
Nuclear bile acid receptor FXR as pharmacological target: are we there yet? 119
Intestinal nuclear receptors in HDL cholesterol metabolism. 119
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 119
Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model 119
Totale 15.084
Categoria #
all - tutte 115.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.594 148 187 31 65 59 191 51 90 113 125 236 298
2022/20232.116 331 224 138 158 223 304 17 256 342 22 51 50
2023/2024855 52 170 37 52 68 211 33 53 7 29 41 102
2024/20254.378 151 30 320 146 105 366 519 380 229 261 585 1.286
2025/20269.582 1.286 428 611 1.084 978 532 969 298 1.012 958 365 1.061
2026/2027789 789 0 0 0 0 0 0 0 0 0 0 0
Totale 27.901